Atlas Trials

Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC

Clinical trial NCT01249638 · UNKNOWN

Trial details

NCT number
NCT01249638
Sponsor
Ludwig-Maximilians - University of Munich
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Colorectal Cancer Metastatic
Start date
2010-12-01
Primary completion
2013-12-01
Enrollment
516

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.